Nursing care
Antidiarrheals: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Antidiarrheals slow intestinal motility or absorb fluid to reduce stool frequency, but they are contraindicated in C. difficile infection and other infectious or inflammatory diarrhoea. Slowing transit traps the causative toxin in the bowel instead of clearing it, which can progress to toxic megacolon. Stool cause must be established before the drug is given.
Mechanism, simply
Loperamide, the drug most nurses will give, acts on opioid receptors in the intestinal wall to slow peristalsis and increase transit time, giving the bowel more time to reabsorb water from the stool. It has minimal central nervous system penetration at therapeutic doses, which is what distinguishes it from opioid analgesics used for the same receptor family.
Bismuth subsalicylate works differently: it has direct antisecretory and mild antimicrobial action against some enteric pathogens, alongside a coating effect on the gut mucosa. Adsorbents such as kaolin-pectin bind water and toxins within the bowel lumen. All three approaches share the same underlying effect of reducing stool frequency, either by slowing the bowel or by binding its contents, rather than treating an underlying infection.
Indications you will see on the ward
Loperamide is used for acute non-infectious diarrhoea, chronic diarrhoea from irritable bowel syndrome, and to manage output from an ileostomy or short bowel syndrome where reducing transit time improves fluid and electrolyte balance. It is also used for chemotherapy-induced diarrhoea once infectious causes have been ruled out.
The case that requires the most caution is diarrhoea of unclear or infectious origin, particularly a hospitalised patient who has recently had antibiotics. That combination raises suspicion for Clostridioides difficile, and it is precisely this population where antidiarrheals are contraindicated. A stool sample and C. diff testing should be considered before reaching for loperamide in any patient with new diarrhoea and a recent antibiotic course, fever, or bloody stool.
Assessment before administration
Establish the likely cause of the diarrhoea before giving anything. Ask about recent antibiotic use, hospitalisation, travel, and food exposure. Check for fever, abdominal distension, bloody or mucoid stool, and severe abdominal pain, all of which point toward an infectious or inflammatory process rather than a simple motility issue.
Assess hydration and electrolyte status, since diarrhoea itself causes fluid and potassium loss regardless of cause. Review the medication and admission history for recent antibiotics specifically, as this is the strongest single risk factor for C. difficile in an inpatient. If infectious diarrhoea, C. difficile, or inflammatory bowel disease is suspected or confirmed, hold the antidiarrheal and notify the provider rather than administering it to control symptoms.
Toxicity and the antidote
Loperamide overdose, including misuse at supratherapeutic doses for its euphoric or opioid-withdrawal-suppressing effect, can cause QT prolongation and torsades de pointes, a risk that increases sharply above recommended doses. Cardiac monitoring and correction of hypokalemia or hypomagnesemia are part of management, since both prolong the QT interval further. Naloxone can reverse the CNS and respiratory depression seen in large overdoses, though its effect is often incomplete and repeat dosing may be needed given loperamide's longer half-life.
In the contraindicated scenario, the harm is not classic drug toxicity but the clinical consequence of the mechanism itself. Slowing motility in C. difficile or another infectious colitis traps the toxin and inflammatory contents in the colon. This can progress to toxic megacolon, a colonic dilation with risk of perforation and sepsis, which carries significant mortality and often requires surgical intervention. There is no antidote for this complication; the only prevention is not giving the drug when it is contraindicated.
Interactions that matter
Loperamide is metabolised via CYP3A4 and P-glycoprotein. Strong inhibitors of either, including quinidine and some antifungals, increase plasma loperamide levels and raise the risk of CNS penetration and cardiac toxicity even at standard doses.
Co-administration with other QT-prolonging drugs, such as certain antipsychotics, antiarrhythmics, and some antibiotics, compounds arrhythmia risk and should prompt closer ECG monitoring. Bismuth subsalicylate contains salicylate and should be used with caution alongside anticoagulants or other salicylates due to additive bleeding risk, and it is avoided in children and teenagers recovering from viral illness because of the Reye syndrome association carried by salicylates generally.
What the patient must be told
Explain that the medication controls symptoms but does not treat an infection, and that it should be stopped and the provider contacted if fever, blood in the stool, or worsening abdominal pain develops. Patients recovering from a course of antibiotics who develop new or watery diarrhoea should be told specifically not to self-treat with an over-the-counter antidiarrheal and to seek evaluation instead.
Reinforce oral rehydration alongside the medication, since slowing stool frequency does not replace the fluid and electrolytes already lost. Warn against exceeding the labelled dose, since misuse for non-medical purposes has caused fatal arrhythmias, and this applies even to an over-the-counter drug patients may not think of as risky. For ostomy or chronic diarrhoea patients on long-term loperamide, teach them to titrate to a target stool consistency under provider guidance rather than a fixed dose.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why is loperamide contraindicated in C. difficile infection?
Slowing bowel motility keeps the C. difficile toxin in contact with the colonic mucosa for longer instead of clearing it. This delay increases the risk of toxic megacolon, a serious and potentially fatal complication.
Can you give loperamide for bloody diarrhoea?
No. Bloody or mucoid stool suggests an infectious or inflammatory cause, which is a contraindication for antidiarrheals. Hold the dose, obtain a stool assessment, and notify the provider.
What is the priority assessment before giving an antidiarrheal?
Establishing the likely cause of the diarrhoea, specifically recent antibiotic use, fever, and stool characteristics, takes priority over giving the drug. Infectious or inflammatory diarrhoea changes the plan entirely.
What are the signs of loperamide-induced cardiac toxicity?
Watch for QT prolongation on ECG, palpitations, dizziness, or syncope, particularly with high-dose or misuse patterns. This risk is elevated further by concurrent hypokalemia or QT-prolonging drugs.
Is bismuth subsalicylate safe in a patient on warfarin?
Use caution. Bismuth subsalicylate contains a salicylate, which can add to bleeding risk in a patient already anticoagulated on warfarin, and the interaction should be flagged to the prescriber.
More on pharmacology
Guides on this